Why in news?
The Pune-based National Institute of Virology (NIV) has developed an immunological assay — enzyme-linked immunosorbent assay (ELISA) — to detect antibodies that the body develops in response to infection by the SARS-CoV-2 novel coronavirus.
Details
- This is the first time India has developed an indigenous ELISA test for coronavirus.
- This kit was validated at two sites in Mumbai and has high sensitivity and accuracy.
- It has the advantage of testing 90 samples together in a single run of 2.5 hours.
- Since the ELISA test is based on detection of antibodies, it can only help in knowing if the person has been previously infected by coronavirus.
Read More about “COVID KAVACH ELISA” here: https://www.legacyias.com/pib-10th-may/
(2nd Article of 10th May PIB summary)
-Source: The Hindu
